About Xtant Medical Holdings (NYSEMKT:BONE)
Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries. It also processes and distributes sports allografts, milled spinal allografts and allografts for multi-disciplinary applications.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Advanced Medical Equipment & Technology
- Sub-Industry: N/A
- Symbol: NYSEMKT:BONE
- CUSIP: N/A
- Web: xtantmedical.com/
- 50 Day Moving Avg: $3.52
- 200 Day Moving Avg: $3.68
- 52 Week Range: $2.19 - $4.75
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.61
- P/E Growth: 0.00
- Net Margins: -45.28%
- Return on Assets: -28.38%
- Average Volume: 12,977 shs.
Frequently Asked Questions for Xtant Medical Holdings (NYSEMKT:BONE)
What is Xtant Medical Holdings' stock symbol?
Xtant Medical Holdings trades on the New York Stock Exchange (NYSE)MKT under the ticker symbol "BONE."
How were Xtant Medical Holdings' earnings last quarter?
Xtant Medical Holdings Inc (NYSEMKT:BONE) issued its earnings results on Wednesday, August, 12th. The company reported ($0.41) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.29) by $0.12. View Xtant Medical Holdings' Earnings History.
Who are some of Xtant Medical Holdings' key competitors?
Some companies that are related to Xtant Medical Holdings include Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Intuitive Surgical (ISRG), Boston Scientific Corporation (BSX), Koninklijke Philips N.V. (PHG), Illumina (ILMN), Cerner Corporation (CERN), Edwards Lifesciences Corporation (EW), Agilent Technologies (A), Waters Corporation (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), PerkinElmer (PKI), ABIOMED (ABMD), Bruker Corporation (BRKR), Alere (ALR) and Quidel Corporation (QDEL).
Who are Xtant Medical Holdings' key executives?
Xtant Medical Holdings' management team includes the folowing people:
- Kent L. Swanson, Independent Chairman of the Board
- Carl D. O'Connell, President, Chief Executive Officer
- Darrel Lee Holmes, Chief Operating Officer
- Gregory Juda Ph.D., Chief Scientific Officer
- David Louis Kirschman M.D., Director
- Paul R. Buckman, Independent Director
- John Deedrick, Independent Director
- Michael A. Lopach CPA, Independent Director
- Rudy A. Mazzocchi, Independent Director
How do I buy Xtant Medical Holdings stock?
Shares of Xtant Medical Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Xtant Medical Holdings' stock price today?
MarketBeat Community Rating for Xtant Medical Holdings (NYSEMKT BONE)MarketBeat's community ratings are surveys of what our community members think about Xtant Medical Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Xtant Medical Holdings stock can currently be purchased for approximately $3.25.
Consensus Ratings for Xtant Medical Holdings (NYSEMKT:BONE) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|Consensus Price Target History for Xtant Medical Holdings (NYSEMKT:BONE)
Analysts' Ratings History for Xtant Medical Holdings (NYSEMKT:BONE)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Xtant Medical Holdings (NYSEMKT:BONE)Earnings History by Quarter for Xtant Medical Holdings (NYSEMKT BONE)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/17/2015||Q414||($0.35)||($0.46)||$8.90 million||$9.10 million||View||N/A|
|8/12/2014||Q214||($0.47)||($0.35)||$8.85 million||$5.60 million||View||N/A|
|5/6/2014||Q114||($0.04)||($0.08)||$9.73 million||$8.90 million||View||N/A|
|3/19/2014||Q413||($0.07)||($0.08)||$8.00 million||$8.30 million||View||N/A|
|11/7/2012||Q312||($0.04)||($0.06)||$9.29 million||$8.90 million||View||N/A|
Earnings Estimates for Xtant Medical Holdings (NYSEMKT:BONE)
Current Year EPS Consensus Estimate: $-1.38 EPS
Next Year EPS Consensus Estimate: $-0.90 EPS
Dividend History for Xtant Medical Holdings (NYSEMKT:BONE)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Xtant Medical Holdings (NYSEMKT:BONE)Insider Trades by Quarter for Xtant Medical Holdings (NYSEMKT:BONE)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/4/2015||Daniel S Goldberger||CEO||Buy||81,522||$3.68||$300,000.96|| |
|9/4/2015||Jon M Wickwire||Director||Buy||10,869||$3.68||$39,997.92|| |
|5/22/2014||Daniel S Goldberger||CEO||Buy||25,000||$0.65||$16,250.00|| |
|5/20/2014||Gregory Alexander Juda||Insider||Buy||20,000||$0.69||$13,800.00|| |
|5/7/2014||Guy S Cook||Major Shareholder||Sell||1,365,000||$0.66||$900,900.00|| |
|5/6/2014||Guy S Cook||Major Shareholder||Sell||885,000||$0.75||$663,750.00|| |
|5/2/2014||Guy S Cook||Major Shareholder||Sell||280,000||$0.73||$204,400.00|| |
|4/30/2014||Guy S Cook||Major Shareholder||Sell||85,000||$0.70||$59,500.00|| |
|4/25/2014||Guy S Cook||Major Shareholder||Sell||100,000||$0.70||$70,000.00|| |
|4/24/2014||Guy S Cook||Major Shareholder||Sell||390,000||$0.70||$273,000.00|| |
|4/22/2014||Guy S Cook||Major Shareholder||Sell||410,000||$0.71||$291,100.00|| |
|4/17/2014||Guy S Cook||Major Shareholder||Sell||75,000||$0.70||$52,500.00|| |
|4/9/2014||Guy S Cook||Major Shareholder||Sell||410,000||$0.72||$295,200.00|| |
|1/15/2014||Guy S Cook||Major Shareholder||Buy||160,000||$0.64||$102,400.00|| |
|1/7/2014||Guy S Cook||Major Shareholder||Sell||273,300||$0.53||$144,849.00|| |
|12/26/2013||Guy S Cook||Major Shareholder||Sell||64,380||$0.53||$34,121.40|| |
|12/24/2013||Guy S Cook||Major Shareholder||Sell||300,000||$0.44||$132,000.00|| |
|12/11/2013||Guy S Cook||Major Shareholder||Sell||160,000||$0.42||$67,200.00|| |
|11/19/2013||Gregory Alexander Juda||Insider||Buy||20,000||$0.45||$9,000.00|| |
|11/12/2013||Daniel S Goldberger||CEO||Buy||50,000||$0.48||$24,000.00|| |
|9/20/2013||Guy S Cook||Major Shareholder||Sell||30,000||$0.60||$18,000.00|| |
|9/13/2013||Darrel Lee Holmes||COO||Sell||30,000||$0.57||$17,100.00|| |
|8/28/2013||Guy S Cook||Major Shareholder||Sell||400,000||$0.56||$224,000.00|| |
|8/26/2013||Daniel S Goldberger||CEO||Buy||20,000||$0.60||$12,000.00|| |
|8/19/2013||Daniel S Goldberger||CEO||Buy||16,194||$0.59||$9,554.46|| |
|8/16/2013||Daniel S Goldberger||CEO||Buy||13,806||$0.58||$8,007.48|| |
|6/18/2013||Guy S Cook||Major Shareholder||Sell||372,859||$0.52||$193,886.68|| |
|6/13/2013||Guy S Cook||Major Shareholder||Sell||175,000||$0.55||$96,250.00|| |
|6/13/2013||Kent L Swanson||Director||Buy||100,000||$0.55||$55,000.00|| |
|6/12/2013||Guy S Cook||Major Shareholder||Sell||2,600||$0.55||$1,430.00|| |
|6/11/2013||Guy S Cook||Major Shareholder||Sell||21,000||$0.56||$11,760.00|| |
|6/10/2013||Guy S Cook||Major Shareholder||Sell||13,400||$0.56||$7,504.00|| |
|6/7/2013||Guy S Cook||Major Shareholder||Sell||88,000||$0.56||$49,280.00|| |
|9/11/2012||Guy S Cook||CEO||Buy||5,000||$1.71||$8,550.00|| |
Headline Trends for Xtant Medical Holdings (NYSEMKT:BONE)
Latest Headlines for Xtant Medical Holdings (NYSEMKT:BONE)
Loading headlines, please wait.
Xtant Medical Holdings (BONE) Chart for Monday, October, 23, 2017